Close Menu

In the Proceedings of the National Academy of Sciences this week, Yale University scientists have developed a cheap, microfluidic platform that uses biocompatible ferrofluids "for the controlled manipulation and rapid separation of both microparticles and live cells." Using microspheres, they achieved 99 percent separation efficiency based on size at less than 10-micron resolution, demonstrating the platform's potential in "significantly reducing incubation times and increasing diagnostic sensitivity in cellular assays

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Russia says its candidate SARS-CoV-2 vaccine has a very high efficacy rate in an initial analysis of clinical trial data, according to the Financial Times.

Wired reports on a microbial analysis of sketches drawn by Leonardo DaVinci.

A new survey explores coronavirus vaccine hesitancy among Black and Latino individuals, the Washington Post reports.

In Nucleic Acids Research this week: the Aging Atlas database, a database of human metagenome-related metadata, and more.